1. | arabidoo | |
2. | forthayer | |
3. | eridine | |
4. | industrialgeneral |
1. | arabidoo | |
2. | forthayer | |
3. | eridine | |
4. | industrialgeneral |
1. | eridine 02/13/2018 Actinium Announces Submission of IND For Actimab-A in Combination with CLAG-M for Patients with Relapsed or Refractory AML |
2. | arabidoo 02/27/2018 Actinium Pharmaceuticals Announces Activation of Sixteenth Clinical Trial Site in the Pivotal Phase 3 SIERRA Trial for Iomab-B |
3. | eridine 02/07/2018 Actinium Pharmaceuticals Announces Trial to Study Actimab-A in Combination with CLAG-M for Relapsed or Refractory AML Patients |
4. | arabidoo 03/13/2018 Actinium Announces FDA Clearance of IND For Phase 1 trial of Actimab-A in Combination with CLAG-M for Patients with Relapsed or Refractory AML |
5. | arabidoo 02/04/2018 Actinium Pharmaceuticals Announces Acceptance of Abstract for AACR Annual Meeting Highlighting Superior In Vivo Survival Data for Actinium Labelled Daratumumab Versus Unlabeled Daratumumab, A Blockbus |